# Liminatus Pharma, Inc.: Form 8-K, filed Jul 17, 2025

- Company: [Liminatus Pharma, Inc.](/companies/limn.md) (CIK 1971387)
- Form: 8-K
- Filed: 2025-07-17
- Accepted by EDGAR: Jul 17, 2025, 16:19 ET
- Period: 2025-07-16
- Accession: 0001104659-25-068670
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1971387/000110465925068670/tm2521089d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971387/000110465925068670/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971387/000110465925068670/tm2521089d1_8k.htm

Filed Jul 17, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-068670. Last ingested by Listed: Nov 3, 2026, 19:32 ET. No prices; not investment advice.